Food and Drug Administration Approval Summary: Odevixibat (Bylvay) for the Treatment of Pruritus With Progressive Familial Intrahepatic CholestasisSoJeong Yi, Ruby Mehta, In‐Sook Kim et al.|Gastro Hep Advances|2024Cited by 6
A Bayesian model for censored positive count data in evaluating breast cancer progressionHung‐Wen Yeh, Byron J. Gajewski, Yu Jiang et al.|Model Assisted Statistics and Applications|2013Cited by 0